New data sheds light on breakthrough COVID-19 cases in Manitoba

The Manitoba government has released new data providing further insights into the province’s breakthrough COVID-19 cases, including which vaccine types and age groups are seeing the most cases post-vaccination.

The Manitoba government has released new data providing further insights into the province’s breakthrough COVID-19 cases, including which vaccine types and age groups are seeing the most cases post-vaccination.

On Monday, the province released its latest respiratory surveillance report, which includes information on COVID-19 cases after full vaccination from Dec. 16, 2020, to Oct. 16, 2021.

The numbers show that more than half of Manitoba’s breakthrough cases among fully vaccinated individuals were in people who received the Pfizer vaccine, while 32.3 per cent were in Manitobans who received Moderna doses.

The data also shows that 14.2 per cent of the breakthrough cases were in fully vaccinated Manitobans who received mixed vaccine types; one per cent were from Manitobans who got AstraZeneca, and only 0.5 per cent of fully vaccinated breakthrough cases were in people who got the Johnson and Johnson vaccine.

It’s important to note that more Manitobans are eligible to receive the Pfizer vaccine compared to any other type, as it’s the only vaccine available to those aged 12 to 17. The province has also received a lot more Pfizer doses than any other vaccine,

Manitoba has received more than 1.5 million doses of Pfizer, more than 800,000 doses of Moderna, and more than 91,000 doses of AstraZeneca.